mortality/aging
• of those that survive to term, 20% die between 3-5 weeks of age
|
• of those that survive to term, 40% die within 48 hours of birth
|
• onset E11.5, incompletely penetrant, some survive to birth and later; phenotype rescued when mothers treated with DOPS
|
growth/size/body
• runting apparent by P7
• by P21, weight about 50% of controls and eventually grow to 80% and 88% of male and female adult weight, respectively
|
• growth phase that occurs normally between 3 and 5 weeks is delayed by one to two weeks
|
vision/eye
cardiovascular system
• greater heterogeneity in cell size and cellular orientation in E12.5-E15.5 embryos
|
homeostasis/metabolism
• in E11.5 embryos
|
• in E11.5 embryos
|
• in E11.5 embryos
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dopamine beta-hydroxylase deficiency | DOID:0090145 |
OMIM:223360 |
J:24414 |